MHCD4401
antibody from Invitrogen Antibodies
Targeting: CD44
CD44R, CSPG8, HCELL, IN, MC56, MDU2, MDU3, MIC4, Pgp1
Antibody data
- Antibody Data
- Antigen structure
- References [8]
- Comments [0]
- Validations
- Other assay [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- MHCD4401 - Provider product page
- Provider
- Invitrogen Antibodies
- Product name
- CD44 Monoclonal Antibody (MEM-85), FITC
- Antibody type
- Monoclonal
- Antigen
- Other
- Description
- Commonly used, FITC conjugates provide relatively high absorptivity, excellent fluorescence quantum yield, and good water solubility.
- Reactivity
- Human
- Host
- Mouse
- Conjugate
- Green dye
- Isotype
- IgG
- Antibody clone number
- MEM-85
- Vial size
- 500 µL
- Storage
- 4° C, store in dark
Submitted references Assessing stemness and proliferation properties of the newly established colon cancer 'stem' cell line, CSC480 and novel approaches to identify dormant cancer cells.
Loss of quiescence and self-renewal capacity of hematopoietic stem cell in an in vitro leukemic niche.
Induction of intestinal stemness and tumorigenicity by aberrant internalization of commensal non-pathogenic E. coli.
Phenotypic and Functional Alterations of Hematopoietic Stem and Progenitor Cells in an In Vitro Leukemia-Induced Microenvironment.
Analysis of the safety of mesenchymal stromal cells secretome for glioblastoma treatment.
Human dental pulp stem cells respond to cues from the rat retina and differentiate to express the retinal neuronal marker rhodopsin.
Bimodal tumor-targeting from microenvironment responsive hyaluronan layer-by-layer (LbL) nanoparticles.
Susceptibility of human placenta derived mesenchymal stromal/stem cells to human herpesviruses infection.
Alowaidi F, Hashimi SM, Alqurashi N, Alhulais R, Ivanovski S, Bellette B, Meedenyia A, Lam A, Wood S
Oncology reports 2018 Jun;39(6):2881-2891
Oncology reports 2018 Jun;39(6):2881-2891
Loss of quiescence and self-renewal capacity of hematopoietic stem cell in an in vitro leukemic niche.
Vanegas NP, Vernot JP
Experimental hematology & oncology 2017;6:2
Experimental hematology & oncology 2017;6:2
Induction of intestinal stemness and tumorigenicity by aberrant internalization of commensal non-pathogenic E. coli.
Sahu U, Choudhury A, Parvez S, Biswas S, Kar S
Cell death & disease 2017 Mar 16;8(3):e2667
Cell death & disease 2017 Mar 16;8(3):e2667
Phenotypic and Functional Alterations of Hematopoietic Stem and Progenitor Cells in an In Vitro Leukemia-Induced Microenvironment.
Vernot JP, Bonilla X, Rodriguez-Pardo V, Vanegas NP
International journal of molecular sciences 2017 Feb 14;18(2)
International journal of molecular sciences 2017 Feb 14;18(2)
Analysis of the safety of mesenchymal stromal cells secretome for glioblastoma treatment.
Onzi GR, Ledur PF, Hainzenreder LD, Bertoni AP, Silva AO, Lenz G, Wink MR
Cytotherapy 2016 Jul;18(7):828-37
Cytotherapy 2016 Jul;18(7):828-37
Human dental pulp stem cells respond to cues from the rat retina and differentiate to express the retinal neuronal marker rhodopsin.
Bray AF, Cevallos RR, Gazarian K, Lamas M
Neuroscience 2014 Nov 7;280:142-55
Neuroscience 2014 Nov 7;280:142-55
Bimodal tumor-targeting from microenvironment responsive hyaluronan layer-by-layer (LbL) nanoparticles.
Dreaden EC, Morton SW, Shopsowitz KE, Choi JH, Deng ZJ, Cho NJ, Hammond PT
ACS nano 2014 Aug 26;8(8):8374-82
ACS nano 2014 Aug 26;8(8):8374-82
Susceptibility of human placenta derived mesenchymal stromal/stem cells to human herpesviruses infection.
Avanzi S, Leoni V, Rotola A, Alviano F, Solimando L, Lanzoni G, Bonsi L, Di Luca D, Marchionni C, Alvisi G, Ripalti A
PloS one 2013;8(8):e71412
PloS one 2013;8(8):e71412
No comments: Submit comment
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Figure 3 Induction of tumorigenic stem cell-like properties in infected host cell. ( a ) Immunofluorescent staining of stem cell (SC) marker CD44. Scale bar=2 mu m. ( b ) FACS analysis of CD44 expression. =iMFI. ( c ) Protein levels of SC markers CD44 and CD133. ( d ) Sphere forming ability, showing (i) morphology, (ii) quantitative number and (iii) arbitrary size of spheroids. Scale bar=100 mu m. ( e ) mRNA levels of multipotency transcription factors and SC markers in adherent cells. ( f ) Self-renewing ability of microbe-induced SCs as measured by primary, secondary and tertiary spheroid formation. ( g ) Protein levels of pNF- kappa B and beta -catenin in spheroids. ( h ) mRNA levels of multipotency transcription factors and SC markers in spheroids. ( i ) Protein levels of SC markers in tumorspheres. ( j ) Tumorigenic ability of CD44 high and CD44 low cells of infected culture, showing (i) morphology and (ii) quantitative size. Scale bar=500 mu m. Data=Mean+-S.D. ( d , e , h ) and Mean+-S.E.M. ( j ) for three experiments; * P
- Conjugate
- Green dye